Table 4. Differentially Expressed Cell Cycle Genes in 15 Brain Regions in SZ. The t-scores were calculated by contrast analysis (GXTM Explorer v.3.0  Gene Logic Inc.) as described previously (Katsel et al  2005a  b)  Genes are arranged in descending order or magnitude of change.

Table S3. Putative MSC markers identified from ANOVA and post hoc analysis

Table S6. Putative Osteogenic markers identified from ANOVA and post hoc analysis

Table S4. Putative Adipogenic markers identified from ANOVA and post hoc analysis

Table 2. Putative markers for undifferentiated MSCs and their differentiated progeny identified from ANOVA and post hoc analysis

Table S5. Putative Chondrogenic markers identified from ANOVA and post hoc analysis

Table 2 Differentially expressed genes in chronic GVHD patients

Table S1. SAM analyses results of 85 TP53 induced genes in high- and low- TP53 patients

Supplemental Table 3B  TAM ?E-like? agonist genes whose expression change with treatment

Supplemental Table 3A.  TAM ?E-like? agonist genes whose expression change with treatment_E upregulated

Supplemental Table 5.  Genes uniquely regulated by TAM

Supplemental Table 1.  E regulated genes that changed with AI and AI+TAM treatment

Supplemental Table 3.  Genes regulated by TAM in the same manner as E

Supplemental Table 4A Genes expressed higher in Nonresponders compared to Responders

Supplemental Table 4B Genes expressed higher in the Responders compared to Nonresponders

Table 1. Characteristics of the CpG islands analyzed

Table 1. Gene expression of deleted YY1 cells versus SaOs-2 wild-type cells

Table S4.2 : List of predictive genes as defined by PAM (S4.1) and KNN (S4.2) analyses

Table III. Transcription changes in Alb:Hdac3^fl/- mice at P17 and P28. the majority of genes that were upregulated at P17 are related to metabolism  but a number of transcription factors  including nuclear hormone receptor gene targets  and cell signalling regulatory molecules were also de-regulated

Table 1. Stem cell self-renewal and maintenance gene expression in bone marrow-derived mesenchymal stem cells (BMSCs) and adipose-derived mesenchymal stem cells18 of which were in the AMSCs  including the important positive regulators of the Wnt pathway FRAT1 and the Wnt receptor Frizzled 1; the cell cycle regulators FGF2  Myc  CDC42  and cyclin D2; and the self renewal markers Myst1 and HSPA9b; No significantly different expressiona